About factor viii recombinant
Recombinant clotting factor VIII
Used for
- Prevention and treatment of bleeding in hemophilia A
- Bleeding control during surgery in hemophilia A
Usual adult dose
Intravenous; dose depends on body weight, target factor level, and bleeding severity. Follow product-specific dosing guidance.
Usual dose in children
Intravenous; dose depends on body weight, target factor level, and bleeding severity. Follow product-specific dosing guidance.
Common side effects
- Headache
- Fever
- Injection-site reactions
- Development of factor VIII inhibitors
Important warnings
- Severe allergic reactions can occur.
- Inhibitors may reduce or eliminate treatment response.
- Not for von Willebrand disease or hemophilia B.
- Dose and monitoring depend on the specific product.
Pregnancy
Limited human data; use when clinically necessary under specialist supervision.
Breastfeeding
Limited information; discuss use with a healthcare professional.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.